Richard Douglas

Richard Douglas

Fortuna: 1 M $ al 31/05/2026

73 años
Health Technology
Consumer Services

Perfil

Richard H.
Douglas
is Independent Chairman at MaxCyte, Inc. since 2021, Chairman at Aldeyra Therapeutics, Inc. since 2016, Independent Director at Novavax, Inc. since 2010, Director at Valneva Usa, Inc. (United States) since 2002, Director at Helio Vision, Inc., and Executive Director at Labyrinth Choir, Inc. Former roles include Director-New Product Development at Integrated Genetics, Inc. from 1982 to 1989 and Senior Vice President-Corporate Development at Genzyme Corp.
from 1989 to 2011.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Michigan.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
20/06/2026 73.220 ( 0,04 % ) 803 223 $ 31/05/2026
09/06/2026 195.000 ( 0,32 % ) 341 250 $ 31/05/2026
17/06/2026 260.998 ( 0,24 % ) 315 808 $ 31/05/2026

Cargos activos de Richard Douglas

EmpresasCargoInicio
IOMAI CORPORATION Director/Miembro de la Junta 01/01/2002
NOVAVAX, INC. Director/Miembro de la Junta 06/08/2010
ALDEYRA THERAPEUTICS, INC. Presidente -
MAXCYTE, INC. Presidente 03/11/2021
Director/Miembro de la Junta -
Director/Miembro de la Junta -

Antiguos cargos conocidos de Richard Douglas.

EmpresasCargoFin
Corporate Officer/Principal 01/01/2011
Corporate Officer/Principal 01/01/1989
Ver el detalle de la experiencia de Richard Douglas.

Formación de Richard Douglas.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

89

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services